More Clarity Pharmaceuticals Ltd. news
Clarity Pharmaceuticals Ltd.ASX: CU6

Clarity Presentation -Bell Potter Healthcare Conference 2022

Nov 9, 2022 at 12:53 AM EST · Issued by Clarity Pharmaceuticals Ltd.

Filed with ASX · Nov 9, 2022 at 12:53 AM EST · 26 pages · English

On 6ix: 6ix.com/news/clarity-presentation-bell-potter-healthcare-conference-2022

Clarity Pharmaceuticals Ltd. on 6ix

In the deck

  • Clarity Pharmaceuticals — Bell Potter Healthcare Conference 202226 slidesNov 9, 2022

Earlier from Clarity Pharmaceuticals

  • 50% recruitment reached for Phase II prostate cancer trialNov 1, 2022
  • Corporate Presentation - Wilsons Drug and Device ConferenceOct 28, 2022
  • 50% recruitment milestone reached for prostate cancer trialOct 26, 2022
  • First patient treated in therapeutic prostate cancer trialOct 6, 2022
  • First participant imaged in Phase II SAR-Bombesin trialOct 5, 2022

Later from Clarity Pharmaceuticals

  • IND approval from the FDA for theranostic SAR-Bombesin trialNov 20, 2022
  • Chairmans Address to ShareholdersNov 23, 2022
  • Managing Directors Presentation to AGMNov 23, 2022
  • Positive topline results from SAR-bisPSMA diagnostic trialDec 13, 2022
  • Diagnostic prostate cancer trial reaches recruitment targetFeb 8, 2023
All Clarity Pharmaceuticals news releases↗

Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.

Follow Clarity Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer